666 related articles for article (PubMed ID: 11049709)
21. Pharmacodynamic profile of daptomycin against Enterococcus species and methicillin-resistant Staphylococcus aureus in a murine thigh infection model.
Dandekar PK; Tessier PR; Williams P; Nightingale CH; Nicolau DP
J Antimicrob Chemother; 2003 Sep; 52(3):405-11. PubMed ID: 12917254
[TBL] [Abstract][Full Text] [Related]
22. Antibiotic and biocide resistance in methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus.
Suller MT; Russell AD
J Hosp Infect; 1999 Dec; 43(4):281-91. PubMed ID: 10658804
[TBL] [Abstract][Full Text] [Related]
23. New bisanthraquinone antibiotics and semi-synthetic derivatives with potent activity against clinical Staphylococcus aureus and Enterococcus faecium isolates.
Socha AM; LaPlante KL; Rowley DC
Bioorg Med Chem; 2006 Dec; 14(24):8446-54. PubMed ID: 16979896
[TBL] [Abstract][Full Text] [Related]
24. In vitro activity of daptomycin against isolates of Staphylococcus aureus and enterococci: first results from Turkey.
Arslan H; Azap OK; Ergin F; Karaman SO; Oruç E
Int J Antimicrob Agents; 2004 Jun; 23(6):642-3. PubMed ID: 15194140
[No Abstract] [Full Text] [Related]
25. Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
Barcia-Macay M; Lemaire S; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
J Antimicrob Chemother; 2006 Dec; 58(6):1177-84. PubMed ID: 17062609
[TBL] [Abstract][Full Text] [Related]
26. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: relationships with antibiotic use and cost drivers.
Mauldin PD; Salgado CD; Durkalski VL; Bosso JA
Ann Pharmacother; 2008 Mar; 42(3):317-26. PubMed ID: 18285560
[TBL] [Abstract][Full Text] [Related]
27. The relationship of a clonal outbreak of Enterococcus faecium vanA to methicillin-resistant Staphylococcus aureus incidence in an Australian hospital.
Bartley PB; Schooneveldt JM; Looke DF; Morton A; Johnson DW; Nimmo GR
J Hosp Infect; 2001 May; 48(1):43-54. PubMed ID: 11358470
[TBL] [Abstract][Full Text] [Related]
28. Design and synthesis of benzenesulfonanilides active against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus.
Namba K; Zheng X; Motoshima K; Kobayashi H; Tai A; Takahashi E; Sasaki K; Okamoto K; Kakuta H
Bioorg Med Chem; 2008 Jun; 16(11):6131-44. PubMed ID: 18468909
[TBL] [Abstract][Full Text] [Related]
29. [Vancomycin resistant enterococci in the Netherlands].
Leavis HL; Willems RJ; Mascini EM; Vandenbroucke-Grauls CM; Bonten MJ
Ned Tijdschr Geneeskd; 2004 May; 148(18):878-82. PubMed ID: 15152389
[TBL] [Abstract][Full Text] [Related]
30. VRE & MRSA. Putting bad bugs out of business.
Sheff B
Nurs Manage; 1999 Jun; 30(6):44-9; quiz 50. PubMed ID: 10562064
[TBL] [Abstract][Full Text] [Related]
31. In vitro efficacy of povidone-iodine solution and cream against methicillin-resistant Staphylococcus aureus.
Goldenheim PD
Postgrad Med J; 1993; 69 Suppl 3():S62-5. PubMed ID: 8290460
[TBL] [Abstract][Full Text] [Related]
32. Interventions to prevent transmission of antimicrobial-resistant bacteria in the intensive care unit.
Huskins WC
Curr Opin Crit Care; 2007 Oct; 13(5):572-7. PubMed ID: 17762238
[TBL] [Abstract][Full Text] [Related]
33. Antimicrobial resistance in gram-positive bacteria.
Rice LB
Am J Med; 2006 Jun; 119(6 Suppl 1):S11-9; discussion S62-70. PubMed ID: 16735146
[TBL] [Abstract][Full Text] [Related]
34. Multicentre surveillance of antibiotic resistance in nosocomial Staphylococcus aureus in Cyprus.
Gourni M; Kontou M; Hadjipanayiotou C; Protopapa P
East Mediterr Health J; 2001; 7(4-5):744-9. PubMed ID: 15332774
[TBL] [Abstract][Full Text] [Related]
35. Antimicrobial activities of hydrophobic 2-arylbenzofurans and an isoflavone against vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus.
Fukai T; Oku Y; Hano Y; Terada S
Planta Med; 2004 Jul; 70(7):685-7. PubMed ID: 15303263
[TBL] [Abstract][Full Text] [Related]
36. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: Position statement from the Joint SHEA and APIC Task Force.
Weber SG; Huang SS; Oriola S; Huskins WC; Noskin GA; Harriman K; Olmsted RN; Bonten M; Lundstrom T; Climo MW; Roghmann MC; Murphy CL; Karchmer TB
Am J Infect Control; 2007 Mar; 35(2):73-85. PubMed ID: 17327185
[TBL] [Abstract][Full Text] [Related]
37. Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis.
Marangon FB; Miller D; Muallem MS; Romano AC; Alfonso EC
Am J Ophthalmol; 2004 Mar; 137(3):453-8. PubMed ID: 15013867
[TBL] [Abstract][Full Text] [Related]
38. [Hospital infection control measures for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci].
Hori S
Nihon Rinsho; 2002 Nov; 60(11):2144-9. PubMed ID: 12440120
[TBL] [Abstract][Full Text] [Related]
39. [Bactericidal effects of commonly used antiseptics/disinfectants on nosocomial bacterial pathogens and the relationship between antibacterial and biocide resistance].
Fiçici SE; Durmaz G; Ilhan S; Akgün Y; Köşgeroğlu N
Mikrobiyol Bul; 2002; 36(3-4):259-69. PubMed ID: 12838659
[TBL] [Abstract][Full Text] [Related]
40. Linezolid and quinupristin/dalfopristin resistance in vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus prior to clinical use in Turkey.
Baysallar M; Kilic A; Aydogan H; Cilli F; Doganci L
Int J Antimicrob Agents; 2004 May; 23(5):510-2. PubMed ID: 15120733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
